@
“ú–{E‘½‘ŠÔ—Õ°ŽŽŒ±‹@\ JMTO
Outline Trial
Šˆ“®•ñ
JMTO RO04-01

‹ÇŠis”ñØœ”ñ‰“Šu“]ˆÚäXŠà‚ɑ΂·‚é­—ÊGemcitabine•úŽËü“¯Žž•¹—p—Ö@‚RTŠÔ‰»Šw—Ö@æs‚RTŠÔ‰Á‘¬‘½•ªŠ„–@‚Ƃ̖³ìˆ×‰»‘æ‚Q‘Š—Õ°ŽŽŒ±


–{ŽŽŒ±Žx‰‡‹@\ F “ú–{E‘½‘ŠÔ—Õ°ŽŽŒ±‹@\
Œ¤‹†ƒOƒ‹[ƒv @ @
Žå”CŒ¤‹†ŽÒ F ‹ž“s‘åŠwˆãŠw•”•‘®•a‰@
@•úŽËü‰È@•½‰ª ^а
•›Žå”CŒ¤‹†ŽÒ F

‹ž“s‘åŠwˆãŠw•”•‘®•a‰@
@•úŽËü‰È@‘剮 ‰Ä¶

“Œv‰ðÍÓ”CŽÒ F (à)æ’[ˆã—ÃU‹»à’c
@—Õ°Œ¤‹†î•ñƒZƒ“ƒ^[
Œ¤‹†Ž––±‹Ç F “ú–{E‘½‘ŠÔ—Õ°ŽŽŒ±‹@\ Ž––±‹Ç
ŽŽŒ±i’» F ƒvƒƒgƒRƒ‹ƒhƒ‰ƒtƒg쬒†
“o˜^ŠJŽn“ú F (–¢’è)
“o˜^I—¹“ú F (–¢’è)
’ÇÕI—¹“ú F (–¢’è)



Œ¤‹†ŠT—v
ŽŸ‰ñì¬



—Õ°ŽŽŒ±‹ÆÑ•ñ‘ˆê——‚Ö


@ @
© COPYRIGHT 1999-2005
JMTO all rights reserved.
This site is link free.

@